ABBV - AbbVie wins FDA nod for new Skyrizi indication
2024-06-20 06:38:57 ET
More on AbbVie
- AbbVie: 5 Reasons That Make A Buy Case
- AbbVie, Inc. (ABBV) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript)
- AbbVie: Turnaround Lurking After The Correction Pain (Upgrade)
- ALS therapy market seen increasing to nearly $1.3B by 2029
- AbbVie urges shareholders to reject mini-tender offer